Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Pollock (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), M. Lonergan (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), B. Miller (Collegeville, PA, United States of America), R. Tal-Singer (Collegeville, PA, United States of America), J. Chalmers (Dundee, United Kingdom). Azurocidin-1: a marker of COPD severity and microbial dysbiosis. 2340

Member's Comments

No comment yet.

Related content which might interest you: Targeting microbes and dysbiosis in severe asthma Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players? Year: 2019 Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation Source: Eur Respir J 2005; 26: Suppl. 49, 251s Year: 2005 Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD Source: Eur Respir J, 56 (4) 2000391; 10.1183/13993003.00391-2020 Year: 2020 The impact of bacterial colonisation on airway inflammation in stable COPD Source: Annual Congress 2012 - COPD is not a pulmonary disease alone Year: 2012 Association between airway bacterial abundance and urinary inflammatory biomarkers in COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Bacterial dysbiosis in pediatric lung diseases such as asthma and CF Source: Virtual Congress 2020 – Bugs secret's: the way the microbiome changes our future Year: 2020 Lung microbiome dysbiosis is associated with mortality in COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease Source: Eur Respir J , 49 (3) 1601328; DOI: 10.1183/13993003.01328-2016 Year: 2017 Bacterial flora in sputum and relationship with lung function in patients with acute exacerbation of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 The respiratory microbiome in chronic obstructive pulmonary disease (COPD) exacerbations: Relationships with clinical characteristics Source: Annual Congress 2012 - Hot topics in respiratory infections Year: 2012 Relationship between bacterial flora and pulmonary function in patients with acute exacerbations of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003 Clinical phenotypes of exacerbation are associated with differences in microbial composition and diversity in COPD Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 What is bacterial colonisation in COPD? Source: Eur Respir Monogr 2015; 69: 161-171 Year: 2015 Presence of bacterial infection influences the severity of symptoms in acute COPD exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 261s Year: 2002 The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 The airway microbiota and exacerbations of COPD Source: ERJ Open Res, 6 (3) 00168-2020; 10.1183/23120541.00168-2020 Year: 2020 Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 The study of airway microbiome and mycobiome of COPD and AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018